Overview Fundamentals API Earnings EOD API Sample Code Pricing

Genprex Inc (GNPX NASDAQ) stock market data APIs

$1.99 0.13(7%) as of July 26, 2024
Price chart is built with Anychart

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Genprex Inc Financial Data Overview

1.86
1.99
-
1.99
1.8
1.77-31
3 904 K
2 099 K
0
-3.69
-0.507
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GNPX',
Type: 'Common Stock',
Name: 'Genprex Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00F7T0157',
ISIN: NULL,
CUSIP: NULL,
CIK: '1595248',
EmployerIdNumber: '90-0772347',
FiscalYearEnd: 'December',
IPODate: '2018-03-29',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Genprex Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -27 794 076
  • Earnings Per Share -18.81
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Genprex Inc Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast -2.54

Get Genprex Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com